Search for Clinical Trial Results

Chromosome Deletion - 16 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Aneuploidies in Embryos and Spermatozoa From Patients With Y-chromosome Microdeletions Condition: Male Sterility Due to Y-chromosome Deletions Date: 2015-08-11 |
Terminated |
Study Name: A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients Condition:
Interventions: Drug: Lenalidomide Dose Level Lenalidomide Schedule |
Completed |
Study Name: Mitochondrial Dysfunction in Phelan-McDermid Syndrome: Explaining Clinical Variation and Providing a Path Towards Treatment Condition: Phelan-McDermid Syndrome Date: 2013-11-25 |
Recruiting |
Study Name: Treatment Strategies for Children With Smith-Magenis Syndrome Condition:
Interventions: |
Recruiting |
Study Name: Expanded Noninvasive Genomic Medical Assessment: The Enigma Study Condition:
Interventions: Other: Blood sampling for Laboratory Developed Test (LDT) analysis Each enrolled subject, either in the |
Recruiting |
Study Name: Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome Condition: Phelan-McDermid Syndrome Date: 2016-03-07 Interventions:
|
Completed |
Study Name: Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome) Condition:
Date: 2012-02-01 Interventions:
|
Completed |
Study Name: Study of the Pathophysiological Mechanisms Involved in Bleeding Events Condition: Oculocerebrorenal Syndrome Date: 2011-03-11 Interventions: Other: Blood sample Blood sample |
Enrolling by invitation |
Study Name: Sulfamethoxazole for the Treatment of Primary PREPL Deficiency Condition:
Date: 2015-10-07 Interventions: Drug: Sulfamethoxazole 60 mg sulfamethoxazole per kg bodyweight (maximal of 3g) divided in 2 doses per d |
Active, not recruiting |
Study Name: RA-2 13-cis Retinoic Acid (Isotretinoin) Condition:
|